The QP needs to have an understanding of the different requirements between commercial and clinical trial operations. This module examines the EU legislation relevant to Investigational Medicinal Products (IMPs), their manufacture, control and supply. Practical guidance on the major differences in GMP expectations between IMPs and commercial products will be given.